Inventor · disambiguated record
Marie-Christine Wolf
Also filed as: WOLF MARIE-CHRISTINE
8 granted patents·8 pending applications·22 citations·filing 2003–2023
85Inventor score
Top patents by PatentIndex Score
16 records- 0188US9382212B1Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2015·Granted Jul 5, 2016·6 cites·24 claims
- 0287US9238627B2Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2013·Granted Jan 19, 2016·7 cites·14 claims
- 0384US9598376B2Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2016·Granted Mar 21, 2017·3 cites·14 claims
- 0484US9562016B2Preparation of and formulation comprising a MEK inhibitorNOVARTIS AG·Filed 2015·Granted Feb 7, 2017·3 cites·16 claims
- 0582US9980944B2Preparation of and formulation comprising a MEK inhibitorARRAY BIOPHARMA INC·Filed 2017·Granted May 29, 2018·2 cites·12 claims
- 0678US10398683B2Preparation of and formulation comprising a MEK inhibitorARRAY BIOPHARMA INC·Filed 2017·Granted Sep 3, 2019·1 cites·23 claims
- 0773US10729678B2Preparation of and formulation comprising a MEK inhibitorARRAY BIOPHARMA INC·Filed 2019·Granted Aug 4, 2020·0 cites·1 claims
- 0869US2024180913A1The therapeutic regimenNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0963US11738028B2Therapeutic regimenNOVARTIS AG·Filed 2021·Granted Aug 29, 2023·0 cites·21 claims
- 1061US2020171037A1Therapeutic regimenNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1154US2018303837A1Therapeutic regimenNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1240US2006057203A1Modified release formulations of oxcarbazepine and derivatives thereofWOLF MARIE-CHRISTINE·Filed 2003·Application pending·0 cites
- 1340US2008187582A1Pharmaceutical Composition Comprising an Indolylmaleimide DerivativeGUITARD PATRICE·Filed 2006·Application pending·0 cites
- 1438US2010209480A1Galenical formulations of organic compoundsALTENBURGER RALF·Filed 2008·Application pending·0 cites
- 1533US2007196488A1Oral matrix formulations comprising licarbazepineKALB OSKAR·Filed 2005·Application pending·0 cites
- 1633US2007190143A1Disintegrating tablets comprising licarb azepineKALB OSKAR·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →